Vasopeptidase inhibition as a new concept in antihypertensive therapy.
Dendorfer
A
A
Institute of Experimental and Clinical Pharmacology and Toxicology, Medical University Lübeck, Germany.
Dominiak
P
P
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001808:Blood Vessels / Q000201:enzymology*; D010450:Endopeptidases / Q000378:metabolism*; D006728:Hormones / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000201:enzymology; D011480:Protease Inhibitors / Q000378:metabolism* / Q000494:pharmacology* / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D013841:Thiazepines / Q000627:therapeutic use
D000959:Antihypertensive Agents; D006728:Hormones; D011480:Protease Inhibitors; D011725:Pyridines; D013841:Thiazepines; C106266:omapatrilat; D010450:Endopeptidases